Historical cnc News Stories
Centene Surges After Strong Q1 Beat & Guidance
Centene (CNC) beat Q1 expectations with $3.37 adjusted EPS, raised full-year guidance, repurchased $1B of debt and reported strong operating cash flow — driving analyst upgrades and a sharp stock rally while enrollment declines remain a watch item.
Centene Faces CMS Crackdown and Value-Based Upside
Recent CMS enforcement actions — a DME enrollment moratorium, withheld Medicaid funds, and tighter price-reporting rules — raise near-term compliance risk for Centene (CNC) while expansion of the ACCESS value-based model offers strategic upside. This article explains the direct implications for Centene’s operations, margins, and investor outlook.
Centene Q4 Fallout: Loss, Guidance, Strategy Shift
Centene reported a $1.1B Q4 loss but beat revenue expectations and issued 2026 guidance above $3 EPS. Membership shifts, Medicare Advantage exits, rising costs, and an AI push frame the near-term recovery story for CNC.
Centene Drops After Minimal CMS Medicare Increase.
Centene (CNC) weakened this week after CMS proposed a nominal 0.09% increase to 2027 Medicare Advantage payments. The muted guidance sent insurers lower, leaving Centene underperforming peers such as Molina amid persistent reimbursement pressure and margin concerns.
Centene Slides After CMS Rates Volatile Week Ahead
Centene (CNC) saw sharp short-term swings this week after CMS proposed a near-flat Medicare Advantage rate update for 2027. A midweek selloff and rebound — combined with elevated trading volume and mixed analyst responses — underline policy-driven margin risk for the insurer and spotlight the stock's sensitivity to healthcare payment decisions.
CMS Cuts Medicare Advantage Hike Hits Centene Stock
Centene (CNC) slid after CMS set a net 0.09% Medicare Advantage payment increase, triggering heavy selling and mixed analyst reactions. Here's what investors must know.